Zobrazeno 1 - 10
of 70
pro vyhledávání: '"M.I. Afanasieva"'
Autor:
N.A. Tmoyan, M.V. Ezhov, O.I. Afanasieva, E.A. Klesareva, M.I. Afanasieva, U.V. Chubykina, S.N. Pokrovsky
Publikováno v:
Atherosclerosis. 355:40-41
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ef67540e68bdff7ced06dcfac631b78
https://doi.org/10.1016/j.atherosclerosis.2022.06.203
https://doi.org/10.1016/j.atherosclerosis.2022.06.203
Autor:
S.N. Pokrovsky, E.A. Klesareva, O. A. Razova, Olga I. Afanasieva, M.I. Afanasieva, Marat V. Ezhov, N.A. Tmoyan
Publikováno v:
Kardiologiia. 59:39-48
Purpose: to study relationship of lipoprotein(a) [Lp(a)], indicators of systemic inflammation and humoral immunity with severity of atherosclerotic involvement of various vascular beds in women.Materials and methods. We included in this study 148 wom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aec65708f3b661705dca2ad64289c6d9
https://doi.org/10.18087/cardio.2019.10.n520
https://doi.org/10.18087/cardio.2019.10.n520
Autor:
Olga I. Afanasieva, I. Yu. Adamova, S.N. Pokrovsky, E. D. Ovchinnikova, P. A. Levashov, O. A. Dmitrieva, M.I. Afanasieva
Publikováno v:
Kardiologicheskii vestnik. :26-32
Цель исследования. Методы терапевтического афереза в мировой клинической практике считаются эффективными для лечения тяже5 лых заболе
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a2a883b1b545603af393a1ba88be7c7
https://doi.org/10.36396/ms.2019.14.03.004
https://doi.org/10.36396/ms.2019.14.03.004
Autor:
L.N. Ilina, E. Vlasova, S. Kurbanov, O.I. Afanasieva, M.I. Afanasieva, A.A. Shiryaev, V.P. Vasiliev, D.M. Galyautdinov, S.N. Pokrovsky, R. Akchurin
Publikováno v:
Atherosclerosis. 355:262
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d5d0af96a9c9fa03e50f189e64ff045
https://doi.org/10.1016/j.atherosclerosis.2022.06.991
https://doi.org/10.1016/j.atherosclerosis.2022.06.991
Autor:
S.N. Pokrovsky, D.M. Galyautdinov, A.A. Shiryaev, E. Vlasova, Olga I. Afanasieva, L.N. Ilina, Akchurin Rs, S. K. Kurbanov, M.I. Afanasieva, V.P. Vasiliev
Publikováno v:
Atherosclerosis. 331:e118-e119
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe25a4f62f6a672bf946e05c172f6ec2
https://doi.org/10.1016/j.atherosclerosis.2021.06.350
https://doi.org/10.1016/j.atherosclerosis.2021.06.350
Publikováno v:
Biomolecules
Biomolecules, Vol 11, Iss 257, p 257 (2021)
Volume 11
Issue 2
Biomolecules, Vol 11, Iss 257, p 257 (2021)
Volume 11
Issue 2
Background: Despite high-intensity lipid-lowering therapy, there is a residual risk of cardiovascular events that could be associated with lipoprotein(a) (Lp(a)). It has been shown that there is an association between elevated Lp(a) level and cardiov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37d1f787a2e9913e2d610dfcc6473b0d
https://pubmed.ncbi.nlm.nih.gov/33578899
https://pubmed.ncbi.nlm.nih.gov/33578899
Autor:
M.I. Afanasieva, Marat V. Ezhov, N.A. Tmoyan, E.A. Klesareva, Olga I. Afanasieva, S.N. Pokrovsky, U Chubykina
Publikováno v:
European Heart Journal. 41
Background Lipoprotein(a) [Lp(a)] is an independent risk factor of cardiovascular disease. The role of Lp(a) and its autoantibodies in the development of atherosclerosis, depending on the severity of lesion, is uncertain. Purpose To define the relati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aae1e6eb8fa2071a67d0bcc1428f806d
https://doi.org/10.1093/ehjci/ehaa946.2937
https://doi.org/10.1093/ehjci/ehaa946.2937
Autor:
M.I. Afanasieva, Marat V. Ezhov, T.V. Balakhonova, Sergei N. Pokrovsky, E.A. Klesareva, N.A. Tmoyan, Olga I. Afanasieva
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 120(3. Vyp. 2)
Lipoprotein(a) [Lp(a)] is a genetically determined risk factor of coronary heart disease and its complications. Meanwhile data about the role of Lp(a) in development of ischemic stroke are controversial.To investigate the association of Lp(a) with at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1282b6ed25449bc38c4bf93b5a051d6f
https://pubmed.ncbi.nlm.nih.gov/32307429
https://pubmed.ncbi.nlm.nih.gov/32307429
Autor:
M.I. Afanasieva, Marat V. Ezhov, Olga I. Afanasieva, N.A. Tmoyan, E.A. Klesareva, O. A. Razova, S.N. Pokrovsky
Publikováno v:
Kardiologiia. 58:45-51
Aim. Lipoprotein(a) [Lp(a)] and low molecular weight (LMW) apolipoprotein(a) [apo(a)] phenotype are risk factors of сoronary heart disease and stroke. Data about the role of Lp(a) and phenotypes apo(a) in the development of lower extremity artery di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce1639094ca0bc5845cd9e3d25cb19d2
https://doi.org/10.18087/cardio.2018.12.10176
https://doi.org/10.18087/cardio.2018.12.10176
Publikováno v:
Atherosclerosis. 331:e117
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f9e33add72edfe48ebfbc79bc0fc15a
https://doi.org/10.1016/j.atherosclerosis.2021.06.344
https://doi.org/10.1016/j.atherosclerosis.2021.06.344